# A Study to Evaluate Cooling Sensation of an Allergy Product in Adults With a History of Allergies

> **NCT04162795** · PHASE4 · COMPLETED · sponsor: **Bayer** · enrollment: 468 (actual)

## Conditions studied

- Allergic Rhinitis

## Interventions

- **DRUG:** Loratadine (Claritin, BAY76-2211)

## Key facts

- **NCT ID:** NCT04162795
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-12
- **Primary completion:** 2019-11-13
- **Final completion:** 2019-11-13
- **Target enrollment:** 468 (ACTUAL)
- **Last updated:** 2021-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04162795

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04162795, "A Study to Evaluate Cooling Sensation of an Allergy Product in Adults With a History of Allergies". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04162795. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*